| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |